4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-026944
PRESIDENT AND CEO sold 30,625 shares at an average $49.50 ($1,516,037)
- PRESIDENT AND CEO acquired 30,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise 10b5-1 | +12,218 | $2.90 | $35,393 | 98,160 | D: show line 1 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Sale 10b5-1 | −12,218 | $49.54 | $605,314 | 85,942 | D: show line 2 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise 10b5-1 | +3,307 | $2.90 | $9,580 | 89,249 | D: show line 3 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Sale 10b5-1 | −3,307 | $50.28 | $166,281 | 85,942 | D: show line 4 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise 10b5-1 | +100 | $2.90 | $290 | 86,042 | D: show line 5 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Sale 10b5-1 | −100 | $51.20 | $5,120 | 85,942 | D: show line 6 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise 10b5-1 | +1,565 | $2.90 | $4,533 | 87,507 | D: show line 7 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Sale 10b5-1 | −1,565 | $49.59 | $77,603 | 85,942 | D: show line 8 in the form |
| Open-market sales · 30,625 sh · avg $49.50 · $1,516,037 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 753,587 | D: show line 19 in the form | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 751,712 | D: show line 20 in the form | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 749,837 | D: show line 21 in the form | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 747,962 | D: show line 22 in the form | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 746,087 | D: show line 23 in the form | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 738,587 | D: show line 24 in the form |
Loading xslF345X05/form4-11152024_091112.xml…